down arrow

Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Chemicals
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
276.80
7.1 (2.63%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 44.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Advanced Enzyme Technologies Ltd stock-summary
stock-summary
Advanced Enzyme Technologies Ltd
Small Cap
Chemicals
Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing and sale of enzymes. Advanced Enzyme Technologies Limited was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra. The Company thereafter, got converted into a Public Company and the name of the Company changed to Advanced Biochemicals Limited on May 28, 1992.
Company Coordinates stock-summary
Company Details
Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi Thane Maharashtra : 400604
stock-summary
Tel: 91-22-41703200
stock-summary
info@advancedenzymes.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 22.36 Cr
Number of Shares
11.18 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Feb-2023
11.18
22.36
2000
2
Issued under ESOP Scheme
30-Sep-2022
11.18
22.36
4250
0
Issued under ESOP Scheme
30-Sep-2022
11.18
22.36
4250
2
Issued under ESOP Scheme
21-Jul-2022
11.18
22.36
11250
0
Issued under ESOP Scheme
21-Jul-2022
11.18
22.36
11250
2
Issued under ESOP Scheme
20-May-2022
11.18
22.36
5900
0
Issued under ESOP Scheme
20-May-2022
11.18
22.36
5900
2
Issued under ESOP Scheme
05-Feb-2022
11.18
22.36
9200
0
Issued under ESOP Scheme
05-Feb-2022
11.18
22.36
9200
2
Issued under ESOP Scheme
02-Nov-2021
11.18
22.36
13175
2
Issued under ESAR
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 8 Schemes (5.57%)

FIIs

Held by 100 FIIs (12.58%)

Promoter with highest holding

Vasant Rathi (33.03%)

Highest Public shareholder

Orbimed Asia Iii Mauritius Fvci Limited (12.07%)

Individual Investors Holdings

16.11%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
MUKUND MADHUSUDAN KABRA
Whole-time director
2.43 cr
KEDAR JAGDISH DESAI
Independent Director
14.7 lacs
VASANT RATHI
Chairman (Non-Executive)
9.9 lacs
Pramod Kasat
Independent Director
12.6 lacs
Sanjay Basantani
Company Sec. & Compli. Officer
0
Rajesh Kumar Sharma
Independent Director
3.4 lacs
Rasika Rathi
Non-Exec & Non-Independent Dir
5.8 lacs
Vindokumar Hiralal Jajoo
Independent Director
9.4 lacs
Sunny Sharma
Non-Exec & Non-Independent Dir
3.3 lacs
Rajshree Patel
Independent Director
7.3 lacs
NITIN JAGANNATH DESHMUKH
Independent Director
3.8 lacs
Vandana Tilak.
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
121.426
0%
 
100
Raw Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Enzymes
222.09
100.00%
 
100
Enzymes
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
169 Cr
(Quarterly Results - Dec 2024)
Net Profit:
38 Cr
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 3,097 Cr (Small Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

1.89%

stock-summary
Debt Equity

-0.34

stock-summary
Return on Equity

11.07%

stock-summary
Price to Book

2.25